Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join


Oct 13, 2022 9:45 AM - Oct 14, 2022 4:30 PM

(US Eastern Standard Time)

Digital Technology in Clinical Trials Conference

Digital Technology in Clinical Trials Conference is now fully virtual. Join us from the comfort of your own space!

Session 8: State of the Union of Real-World Evidence (RWE) and Real-World Data (RWD): How Can we use RWD technology in the Drug Development Space? and Closing Remarks

Session Chair(s)

Keith  Wenzel

Keith Wenzel


DIA Study Endpoints Community, United States

With the continued adoption and expansion of real-world evidence (RWE) submissions being accepted by regulatory authorities, the demand for research supported by leveraging the appropriate real-world data (RWD) has facilitated the demand for higher expectations and improved best practices. This session will review today’s RWE successes and put forth the vision for where RWE is going in life sciences. Diverse RWE case studies will be presented as well as the future of RWE including insight to regulators, efficient electronic health care data extraction, RWD-driven site selection, and patient-controlled access to RWD.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Identify different scenarios for leveraging real-world data across the drug development spectrum
  • Distinguish how realistic evolving technology and methods are such as targeted learning and EHR extraction
  • Discuss patient centricity and how patients controlling access to RWD may restrict or enable clinical research


Sanghita  Bhattacharya, PhD


Sanghita Bhattacharya, PhD

Johnson & Johnson Innovative Medicine, United States

Associate Director Data Science , Feasibility and Analytics, Clinical Operations

Sam  Roosz, MBA

Sam Roosz, MBA

Crescendo Health, United States

Co-Founder and CEO

Edgar  Simard, PhD, MPH


Edgar Simard, PhD, MPH

Verily Life Sciences, United States

Head of Epidemiology, Biostatistics, and Data Management

Elena  Izmailova, PhD

Elena Izmailova, PhD

Koneksa, United States

Chief Scientific Officer

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.